Cinctive Capital Management »

Urogen Pharma shares owned by Cinctive Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Cinctive Capital Management from 13F filings

Historical chart of Cinctive Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Cinctive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Cinctive Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $398k 17k 23.42

More positions owned by Cinctive Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Vistra Energy (VST)
Chevron Corporation (CVX)
Frontier Communications Pare
EXACT Sciences Corporation (EXAS)
Cyberark Software SHS (CYBR)
Lifezone Metals Ord Shs (LZM)
Kinder Morgan (KMI)
Sempra Energy (SRE)
Atlassian Corporation Cl A (TEAM)
NVIDIA Corporation (NVDA)
Constellation Energy (CEG)
Ross Stores (ROST)
Bank of America Corporation (BAC)
Waterbridge Infrastructure L Cl A Shs Repstg (WBI)

View all positions for Cinctive Capital Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
Caption Management
MPM Oncology Impact Management
D. E. Shaw & Co

View all funds holding Urogen Pharma